MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)
Hong Kong · Delayed Price · Currency is HKD 7.91
+0.11 (1.41%)
May 11, 2026, 4:08 PM HKT
HKG:2235 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 660.79 | 340.35 | 248.35 | 169.89 | 151.4 |
Other Revenue | - | 5.26 | 4.88 | 3.72 | - |
| 660.79 | 345.62 | 253.23 | 173.61 | 151.4 | |
Revenue Growth (YoY) | 91.19% | 36.48% | 45.86% | 14.67% | 101.13% |
Cost of Revenue | 303.36 | 166.54 | 136.08 | 93.91 | 80.52 |
Gross Profit | 357.42 | 179.08 | 117.14 | 79.69 | 70.88 |
Selling, General & Admin | 271.34 | 249.28 | 250.62 | 158.23 | 93.74 |
Research & Development | 76.34 | 76.56 | 70.1 | 61.09 | 36.08 |
Other Operating Expenses | -9.61 | -0.79 | -9.28 | -21.99 | - |
Operating Expenses | 339.61 | 326.49 | 312.43 | 200.04 | 131.05 |
Operating Income | 17.82 | -147.41 | -195.29 | -120.34 | -60.17 |
Interest Expense | -0.13 | -0.68 | -0.05 | -0.15 | -0.02 |
Interest & Investment Income | 53.9 | 64.25 | 68.24 | 55.72 | 24.49 |
Currency Exchange Gain (Loss) | - | 9.7 | 7.11 | 29.95 | -16.48 |
Other Non Operating Income (Expenses) | -22.04 | -0.3 | -4.68 | -0.22 | 3.97 |
EBT Excluding Unusual Items | 49.55 | -74.44 | -124.67 | -35.03 | -48.2 |
Gain (Loss) on Sale of Investments | -0.03 | 0.09 | -0.02 | - | - |
Gain (Loss) on Sale of Assets | 0.01 | - | - | -0.01 | 0.05 |
Asset Writedown | -9.12 | -0.83 | -0.16 | -0 | - |
Other Unusual Items | - | 12.03 | 0 | - | - |
Pretax Income | 40.4 | -63.15 | -124.85 | -35.04 | -48.15 |
Income Tax Expense | 0.25 | -0.03 | 0.16 | 0 | - |
Earnings From Continuing Operations | 40.15 | -63.12 | -125.02 | -35.04 | -48.15 |
Net Income | 40.15 | -63.12 | -125.02 | -35.04 | -48.15 |
Net Income to Common | 40.15 | -63.12 | -125.02 | -35.04 | -48.15 |
Shares Outstanding (Basic) | 402 | 418 | 431 | 438 | 373 |
Shares Outstanding (Diluted) | 402 | 418 | 431 | 438 | 373 |
Shares Change (YoY) | -3.93% | -3.05% | -1.59% | 17.39% | 21.79% |
EPS (Basic) | 0.10 | -0.15 | -0.29 | -0.08 | -0.13 |
EPS (Diluted) | 0.10 | -0.15 | -0.29 | -0.08 | -0.13 |
Free Cash Flow | - | -120.65 | -153 | -148.79 | -61.82 |
Free Cash Flow Per Share | - | -0.29 | -0.35 | -0.34 | -0.17 |
Gross Margin | 54.09% | 51.81% | 46.26% | 45.91% | 46.82% |
Operating Margin | 2.70% | -42.65% | -77.12% | -69.32% | -39.74% |
Profit Margin | 6.08% | -18.26% | -49.37% | -20.18% | -31.80% |
Free Cash Flow Margin | - | -34.91% | -60.42% | -85.71% | -40.83% |
EBITDA | 29.02 | -136.21 | -184.12 | -110.19 | -52.28 |
EBITDA Margin | 4.39% | -39.41% | -72.71% | -63.47% | -34.53% |
D&A For EBITDA | 11.2 | 11.2 | 11.17 | 10.15 | 7.88 |
EBIT | 17.82 | -147.41 | -195.29 | -120.34 | -60.17 |
EBIT Margin | 2.70% | -42.65% | -77.12% | -69.32% | -39.74% |
Effective Tax Rate | 0.62% | - | - | - | - |
Revenue as Reported | - | 345.62 | 253.23 | 173.61 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.